In the report PNC highlight 3 possibilities to solve liquidity issues: sale of assets, refinance & equity issue.
Potential impact of each
Sale of assets
PDL's are the obvious main asset totalling $249.8m.
Short term borrowings are currently $169.4m
So to clear 100% of the debt PNC would need to sell approx 67.8% of PDL's at book value.
Cash generated from Liquidations in accounts for FY19 $120.8m, so a pro rata reduction in Liquidations would mean a reduction in cash of -$82.0m, that would have reduced Cashflow from operations in FY19 to -$30.4m
With payments to suppliers & employees $55.3m PNC would need to slash it's workforce in more than half to breakeven.
It would take the company 5-10+ years to recover to it's pre crisis level IMO.
Refinance
Assuming a 2% increase in finance costs on $169.4 after tax would reduce cashflow from operations by $2.4m.
Cashflow per share in this case would fall to 77.6c, not a huge impact.
Share price after initial turbulence should recover to a pre crisis level in 2-5 years IMO.
Equity issue.
To 100% cear the borrowings of $169.4m would require 84.7m shares to be issued assuming a price of $2.00 (arbitrary number). That's a 133.6% in shares in issue.
Cashflow in operations of $51.6m would increase by $4.675 by eliminating interest charges & impact of tax to $56.3m.
With 148.1m shares in issue that would reduce the cash flow per share to 38.0c a reduction of 53.3% on FY19. A huge hit for current shareholders, again a 5-10 year recovery period IMO.
So as far as I can see unless the company refinances the current borrowing facilities shareholders are going to take a substantial hit unless there is a total takeover which doesn't appear to be on the cards.
- Forums
- ASX - By Stock
- PNC
- Ann: FY19 Annual Report (with App 4E)
Ann: FY19 Annual Report (with App 4E), page-21
Featured News
Add PNC (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4900 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
63.0¢ | 17836 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4900 | 0.615 |
1 | 20689 | 0.605 |
2 | 111977 | 0.600 |
1 | 18019 | 0.555 |
1 | 100000 | 0.550 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 17836 | 2 |
0.640 | 13437 | 1 |
0.650 | 18199 | 2 |
0.655 | 19982 | 1 |
0.660 | 40000 | 1 |
Last trade - 11.18am 15/11/2024 (20 minute delay) ? |
Featured News
PNC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online